Newark Beth Israel breaks ties with director of troubled heart transplant program

© Copyright ASC COMMUNICATIONS 2020. Intrigued in LINKING to or REPRINTING this content? View our policies by clicking here.

Newark Beth Israel said it will quickly start a nationwide search for a new heart transplant program director.

Newark Beth Israel said Dr. Zucker and hospital leaders “equally concurred that this is an appropriate time for a formal leadership shift,” according to a health center news release shown Beckers..

Mackenzie Bean –
Monday, November 2nd, 2020

CMS investigated Newark Beth Israel after ProPublicas exposé and recognized a number of shortages with the heart transplant program, which the healthcare facility has actually given that remedied. The hospital employed outside specialists to conduct its own investigation, which discovered that Dr. Zucker and the transplant teams post-transplant take care of the patient was not unethical or jeopardized by issues about survival rates, according to the medical facility.

Dr. Zucker will no longer be associated with Newark Beth Israel but will still keep advantages to treat personal patients at other RWJBarnabas Health hospitals. West Orange, N.J.-based RWJBarnabas Health is Newark Beth Israels parent system.

More articles on cardiology: MRIs safe for patients with implanted heart devices, study findsPhysician perspective: We require to work on gender equity in cardiologyThis is apocalyptic: El Paso cardiologist says COVID-19 surge is threatening heart clients lives.

Health center leaders put Dr. Zucker on administrative leave last year after an October 2019 ProPublica examination accused the healthcare facility of keeping a patient in a vegetative state alive for a year to enhance the transplant programs survival rate. Recordings gotten by the newsroom program Dr. Zucker advised health center personnel to avoid providing the patients family the choice to withdraw care and switch to palliative treatments up until after September 2019, or one year after his transplant.

” Newark Beth Israel Medical Center has always had a credibility for offering high quality care, modern care, and I am really happy to have actually worked there for more than three decades, served the neighborhood with honor, and contributed substantially to that reputation,” Dr. Zucker stated in a declaration that his attorney sent out to ProPublica.

© Copyright ASC COMMUNICATIONS 2020. Intrigued in LINKING to or REPRINTING this content? View our policies by clicking here.

Mark Zucker, MD, director of Newark (N.J.) Beth Israel Medical Centers heart transplant program left his function Oct. 30 after being on administrative leave for the last year, reports ProPublica.